Position in GRAL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$5,794,464
-$3,477,072 QoQ
Shares Held
112,122
+3.5% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $900,125,408 across 26 Diagnostics & Research names. GRAL ranks #18 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
234,653 | $131,849,174 | |
| 2 | NTRA |
Natera, Inc.
|
528,798 | $105,754,312 | |
| 3 | ILMN |
Illumina, Inc.
|
734,621 | $90,549,384 | |
| 4 | WAT |
Waters Corp /De/
|
303,112 | $90,266,753 | |
| 5 | A |
Agilent Technologies, Inc.
|
786,052 | $89,594,206 | |
| 6 | VCYT |
Veracyte, Inc.
|
2,117,046 | $68,190,051 | |
| 7 | DGX |
Quest Diagnostics Inc
|
329,152 | $64,507,208 | |
| 8 | LH |
Labcorp Holdings Inc.
|
217,402 | $58,005,026 |
All Filings in GRAL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,794,464 | 112,122 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,271,536 | 108,325 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | $772,204 | 50,241 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||